Clover Health launches drug development subsidiary
FierceHealthIT
JULY 11, 2019
Startup Medicare Advantage insurer Clover Health has launched a new drug development subsidiary called Clover Therapeutics.
91 
Bonus Features – June 26, 2022 – Walgreens gets into clinical trials, ONC offering SDOH grants, and more
Healthcare IT Today
JUNE 26, 2022
This amounts to savings of 55% to 70% for Medicare beneficiaries who are part of a knee or hip replacement bundled payment program. The Office of the National Coordinator for Health IT has some money for you.
Join 82,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
New Blockchain ledger will let US residents sell personal Healthcare data
Lloyd Price
SEPTEMBER 9, 2018
Most people don't know it but there is a multi-billion dollar industry that collects healthcare information, strips it of basic personal identifiers such as name, address and Social Security Number, and then sells it off to researchers, drug developers, marketers and others. Both SimplyVital Health and Hu-manity.co
Blockchain in Healthcare: A Vehicle Towards Digital Health 2.0?
The Digital Health Corner
MARCH 26, 2018
Blockchain technology’s potential impact on the life sciences industry (drug development, distribution and prescribing) is significant. It can impact the opioid crisis and improve tracking drugs in the supply chain. One can envision how blockchain might also stop drug counterfeiting thereby improving patient safety.
Pharma – 2023 Health IT Predictions
Healthcare IT Today
JANUARY 9, 2023
In 2023, we will see more pharma companies integrating precision medicine programs with drug development programs, as well as increasing regulation on precision medicine solutions and/or tools that are combining machine learning and AI. The big question that remains is who will have access to these drugs and when?
Uses of AI in Healthcare – 2024 Health IT Predictions
Healthcare IT Today
JANUARY 17, 2024
Precision medicine will continue to evolve in 2024: In disease areas like oncology, we will start to see AI playing a larger role in target discovery and biomarker or patient subpopulation identification, the cornerstones to early precision drug development.
Let's personalize your content